Skip to main content

Dysregulation of FGFR1 signaling in the hippocampus facilitates depressive disorder.

Shin J, Oh H, Park JH, Bae H, Yang CM, Lee M, Kim S, Heo WD
Exp Mol Med. 2025 Aug;57(8):1818-1836. doi: 10.1038/s12276-025-01519-9. Epub 2025 Aug 15. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
250235AAV-hSyn-DIO-optoFGFR1-HACre-dependent AAV expressing light-activatable FGFR1 (optoFGFR1-HA) for temporally precise control of neuronal FGFR1 signaling
250236AAV-CaMKIIα-optoFGFR1-HAAAV expressing light-activatable FGFR1 (optoFGFR1-HA) under the CaMKIIα promoter for excitatory-neuron-specific activation
250237AAV-EF1α-DIO-DSE-mCherry-PSE-shRNA-ScrambleCre-dependent AAV expressing mCherry and a scrambled shRNA under EF1α promoter. Used as a non-targeting control for shRNA knockdown
250238AAV-EF1α-DIO-DSE-mCherry-PSE-shRNA-NumbCre-dependent AAV expressing mCherry and an shRNA targeting Numb under EF1α promoter for selective Numb knockdown

Antibodies from Article